Metraipolis › archive › dc_1fe4002e5a44
Optimization of linezolid infusion duration in critically ill patients: a population pharmacokinetic analysis of the trade-off between efficacy and toxicity — Europe PMC PMID:42453586
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42453586
- DOI
- 10.3389/fphar.2026.1766346
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T14:21:57.833Z
- SHA-256 of the archived text
e3becc58b9171a8446f5dcedec0ab71e418bafbc55455a69f35504945a2eced9- Stable URL of this page
https://metraipolis.com/documento/dc_1fe4002e5a44
How to cite
Optimization of linezolid infusion duration in critically ill patients: a population pharmacokinetic analysis of the trade-off between efficacy and toxicity — Europe PMC PMID:42453586 — Europe PMC (en), https://europepmc.org/article/MED/42453586 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1fe4002e5a44 (Metraipolis archive dc_1fe4002e5a44, sha256 e3becc58b9171a8446f5dcedec0ab71e418bafbc55455a69f35504945a2eced9)
BibTeX
@misc{dc1fe4002e5a44,
title = {Optimization of linezolid infusion duration in critically ill patients: a population pharmacokinetic analysis of the trade-off between efficacy and toxicity — Europe PMC PMID:42453586},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42453586},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1fe4002e5a44; sha256 e3becc58b9171a8446f5dcedec0ab71e418bafbc55455a69f35504945a2eced9},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42453586. Agents can read the archived copy with the MCP tool read_document.